Candesartan Hair Loss: Risk, Timeline & Fixes

Last updated How we write and review our guides

One of the questions people type into search engines is a comparison: is candesartan more likely than telmisartan to cause hair loss? The labels cannot settle it, because neither drug names alopecia in the US or UK information I read.[1][3][5]

That shapes how candesartan hair loss should be approached. There is no label entry to point at, so the useful evidence is your own story: when you started the medicine, when the shedding began, what the pattern looks like, and what else happened in those months. This page walks through that, using the questions readers actually ask.

Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change candesartan without clinician guidance. If you are not sure whether you are seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, facial swelling, or rapid worsening, start here: When to See a Doctor.

Candesartan hair loss: ARB shedding, telogen effluvium timing, diffuse pattern clues, overlap triggers, labs, and practical next steps.
Suspected candesartan-related shedding is usually best interpreted through delayed telogen effluvium timing and a diffuse pattern, not a sudden one-week cause.

Key points


Quick navigation


What the product information says (and doesn’t)

US labeling (Atacand)

  • Common trial events: in placebo-controlled hypertension trials (2,350 patients on candesartan, 1,027 on placebo), events in at least 1% of patients and more often than placebo were back pain (3% vs 2%), dizziness (4% vs 3%), upper respiratory tract infection (6% vs 4%), pharyngitis (2% vs 1%) and rhinitis (2% vs 1%).[1]
  • Stopping treatment: discontinuation for a clinical adverse event was 2.4% (57 of 2,350) with candesartan versus 3.4% (35 of 1,027) with placebo.[1]
  • Post-marketing reports: the only skin entry is “Skin and Appendages Disorders: Pruritus, rash and urticaria.” Alopecia is not listed.[1]

UK product information

  • The candesartan 8 mg SmPC from Aurobindo/Milpharm (revised May 2026) lists one skin entry for both hypertension and heart failure, with frequency “very rare”: angioedema, rash, urticaria and pruritus. Alopecia and hair loss do not appear.[3]
  • The candesartan 8 mg SmPC from Krka (text dated November 2020) has the same entry and also no mention of alopecia.[4]

Combination tablets (candesartan with hydrochlorothiazide)

The US Atacand HCT label lists “exfoliative dermatitis including toxic epidermal necrolysis, alopecia” under the adverse experiences of hydrochlorothiazide, and “pruritus and urticaria” as its post-marketing skin entry.[2] So if you take a combination tablet, the second ingredient has its own label; see our hydrochlorothiazide page.

How it compares with other ARBs

The US telmisartan label I read does not name alopecia either,[5] while the US olmesartan and valsartan labels list it among post-marketing reports.[6][7] See our olmesartan, valsartan and telmisartan pages for details. DermNet’s list of drugs that cause TE names antihypertensives only as “beta-blockers, ACE inhibitors,” and I found no published case reports for candesartan.[10]

What this means in practice: an absent label entry lowers the likelihood that candesartan is the culprit, but it cannot rule it out, because rare reactions may never reach a label. The decision should rest on whether the timeline fits TE, whether the pattern is diffuse, and whether there were other triggers in the same window.

Timeline: onset, shedding phase, recovery

  • Onset: the key clue is delay. DermNet says hair fall is noticed 2 to 4 months after the trigger; BAD says it can occur around 3 months after.[8][9]
  • Shedding phase: BAD gives 3 to 6 months, and calls TE chronic if it lasts more than 6 months.[9]
  • Recovery: DermNet says hair fall tapers back to normal over 6 to 9 months in most cases, and BAD says it may take many months for hair to return to normal volume and thickness.[8][9]
  • If a drug is the cause and is stopped under medical advice: DermNet says shedding settles within up to 6 months, with regrowth visible within 3 to 6 months and cosmetic recovery sometimes taking 12 to 18 months.[10]

This delay is why the link is easy to miss: someone starts candesartan, feels stable for weeks, and only later notices more hair in the shower, on the pillow or on the brush. The same window also fits illness, surgery, weight change or stress.

Pattern clues: TE vs AGA vs AA vs breakage

Most consistent with TE

Medication-linked or trigger-linked TE usually looks like diffuse shedding with a generally normal-looking scalp: more hair fall all over, not one sharply defined bald patch.

TE + androgenetic alopecia overlap

If shedding improves but the part line keeps widening or the crown continues to thin, think about overlap with telogen effluvium vs androgenetic alopecia.

Alopecia areata is a different pattern

If you have patchy, smooth, well-defined bald areas, that is less typical for medication-triggered TE and should raise the question of alopecia areata.

Breakage is not the same as shedding

If you mostly see short snapped hairs, rough texture or frayed ends, that points more toward hair breakage than true root-level shedding.

If the scalp is inflamed, think broader than TE

TE is typically non-scarring and without obvious inflammation. If the scalp is very itchy, red, painful or crusted, a simple TE explanation is incomplete; see Itchy Scalp and Hair Loss.

When labs matter

Not everyone with a plausible timeline needs a broad lab panel. DermNet lists at least a blood count, iron studies and thyroid function tests when the cause is unclear, and BAD mentions blood tests to exclude conditions such as thyroid problems and iron deficiency.[10][9] They matter most when shedding is heavy, persistent or recurrent, or the history suggests iron deficiency, thyroid disease, major weight change, illness or dietary restriction in the same window.

For the site workup roadmap, use: Blood Tests & Workup. For the most common overlaps, see low ferritin and shedding and thyroid hair loss vs TE.

What to do (practical plan)

  1. Build the timeline: write down the candesartan start date, any dose changes, and the month shedding became noticeable.
  2. Confirm the pattern: diffuse shedding vs breakage vs overlapping pattern hair loss vs patchy loss.
  3. Review stacked triggers: illness, fever, surgery, postpartum timing, dieting, weight loss, thyroid issues, low iron or major stress. BAD notes that for 1 in 3 people with TE no cause is found, and DermNet suggests looking back over the three months before the hair loss began.[9][10]
  4. Check the exact formulation: candesartan alone versus a combination with hydrochlorothiazide, because each ingredient has its own label.[2]
  5. Talk to the prescriber: if the timing fits, discuss whether to wait and watch or consider an alternative, weighing the cardiovascular benefit. Do not self-stop.
  6. Avoid supplement roulette: BAD advises supplements only if your diet is restricted, and notes that medication does not speed up TE regrowth.[9]
  7. Track monthly: photos every 4 weeks in the same lighting and angle, to judge the trend rather than day-to-day anxiety.

Stress is a common co-trigger; see Hair Loss After Stress.

When to see a doctor

  • Scalp pain, burning, pustules, open sores, or heavy scale/crusting
  • Patchy smooth bald spots rather than diffuse shedding
  • Obvious eyebrow or eyelash involvement
  • Facial, lip or tongue swelling, or hives: seek urgent care, since angioedema is a reported reaction to candesartan
  • Shedding that persists beyond about 6 months or returns in repeated waves
  • Unclear diagnosis or rapid worsening

Start here: When to See a Doctor.


FAQ

Does candesartan cause hair loss?

The labels I read do not list it, and I found no published case reports, so there is no documented link.[1][3] That does not exclude an individual reaction, so the timeline and other triggers still need to be reviewed. Online reviews and forum posts are anecdotes and cannot show that a drug was the cause.

Which is more likely to cause hair loss, telmisartan or candesartan?

The labels do not allow a ranking: neither names alopecia in the US or UK information I read.[1][3][5] Individual timing and other triggers matter more than the choice between the two; see our telmisartan page.

Can candesartan cause an itchy scalp or scalp irritation?

Pruritus (itching) is listed as a post-marketing entry in the US label and as “very rare” in the UK documents, but neither specifies the scalp.[1][3] An itchy, irritated scalp with shedding has many other causes; see itchy scalp and hair loss.

Can candesartan cause hair loss in women?

I found no label or study data comparing men and women for this reaction. DermNet describes acute TE as affecting both sexes at any age.[8] If you are a woman with thinning, TE and female pattern hair loss can overlap; see female pattern hair loss vs TE.

Does candesartan help hair growth or thickness?

I found no source showing that it does. The labels I read cover high blood pressure and heart failure, not hair. If you want to treat thinning, start with the cause; see our minoxidil hub for a prescriber-guided option.

Does hair grow back after stopping candesartan?

If a drug was the trigger and was stopped on medical advice, DermNet says shedding settles within up to 6 months and regrowth is usually seen within 3 to 6 months, though full cosmetic recovery can take 12 to 18 months.[10] Stopping should be the prescriber’s decision, because the blood pressure or heart condition still needs treatment.

Why does shedding start months later?

Because TE is delayed: the trigger shifts more hairs into the resting phase first, and the increased shedding becomes noticeable once those hairs are pushed out, typically 2 to 4 months later.[8]

Should I stop candesartan if I suspect shedding?

No, not on your own. The UK information reports no indication of a rebound effect after stopping treatment, but that does not mean blood pressure or heart failure stays controlled without it.[3] Review the timeline and treatment context with the prescriber first.


References (trusted sources)

  1. Medlibrary: Atacand (candesartan cilexetil) prescribing information — hypertension trial adverse events, discontinuation and post-marketing list
  2. Medlibrary: Atacand HCT (candesartan/hydrochlorothiazide) prescribing information — adverse experiences and post-marketing list
  3. UK electronic medicines compendium: Candesartan cilexetil 8 mg tablets SmPC (Aurobindo/Milpharm, revised May 2026)
  4. UK electronic medicines compendium: Candesartan cilexetil 8 mg tablets SmPC (Krka, text dated November 2020)
  5. Medlibrary: Micardis (telmisartan) prescribing information, post-marketing experience
  6. Medlibrary: Benicar (olmesartan medoxomil) prescribing information, post-marketing experience
  7. Medlibrary: Diovan (valsartan) prescribing information, post-marketing experience
  8. DermNet NZ: Telogen effluvium (hair fall noticed 2–4 months after trigger)
  9. British Association of Dermatologists (Skin Health Info): Telogen effluvium (around 3 months after a trigger)
  10. DermNet NZ: Alopecia from drugs

TOUATI

I have lived with hair loss since 2019. After consulting several doctors and researching every day, I founded Hair Health Blog to share clear, evidence-based answers with people facing the same problem. Not a doctor; always consult a dermatologist.facebook instagram

Previous Post Next Post

Contact Form